Moringa for Anti-Inflammatory

Research suggests that Moringa oleifera demonstrates meaningful anti-inflammatory activity across a range of laboratory, animal, and review-level studies, with multiple bioactive compounds — including isothiocyanates, flavonoids like quercetin and kaempferol, and specific seed proteins such as Mo-CBP4 — appearing to reduce levels of key inflammatory markers like TNF-α, IL-1β, and IL-6. Studies indicate that moringa extracts have shown effects comparable to standard anti-inflammatory drugs in some animal models, and a 2022 rat study found high-dose moringa extract produced anti-inflammatory effects linked to reductions in these same signaling molecules, while a 2024 animal study reported that a seed-derived protein reduced intestinal inflammation during chemotherapy without interfering with cancer cell death. The available evidence comes primarily from preclinical sources — including in vitro cell studies, animal models, and narrative or systematic reviews — with no robust human clinical trials yet establishing efficacy or safety for anti-inflammatory use in people. A notable limitation highlighted in a 2024 study is that active compounds in moringa leaf extracts may degrade significantly during digestion, suggesting that bioavailability in humans remains an unresolved challenge that future research would need to address.